Jiangbo Wang Selected Research

Niclosamide

1/2019	Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype.
1/2019	Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy.
11/2018	Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth.
1/2018	Niclosamide: Beyond an antihelminthic drug.
8/2017	Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth.
1/2017	Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis.
9/2015	Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiangbo Wang Research Topics

Disease

7	Neoplasms (Cancer) 01/2019 - 06/2012
4	Colonic Neoplasms (Colon Cancer) 11/2018 - 09/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2018
2	Inflammation (Inflammations) 12/2017 - 03/2014
2	Non-alcoholic Fatty Liver Disease 08/2017 - 09/2015
2	Virus Diseases (Viral Diseases) 08/2017 - 09/2015
2	Breast Neoplasms (Breast Cancer) 02/2015 - 06/2012
1	Parasitic Diseases (Parasitic Disease) 01/2018
1	Atherosclerosis 12/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2017
1	Fibrosis (Cirrhosis) 05/2017
1	Cardiomyopathies (Cardiomyopathy) 05/2017
1	Respiratory Insufficiency (Respiratory Failure) 09/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2016
1	Metabolic Diseases (Metabolic Disease) 09/2015
1	Glioblastoma (Glioblastoma Multiforme) 01/2015

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 01/2019 - 02/2015
7	Niclosamide FDA Link 01/2019 - 09/2015
6	CateninsIBA 01/2019 - 09/2015
5	AnthelminticsIBA 01/2019 - 09/2015
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2012
2	Biological ProductsIBA 08/2017 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 02/2015 - 06/2012
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Frizzled ReceptorsIBA 01/2019
1	Mitogen-Activated Protein Kinase 3IBA 12/2017
1	Perilipin-2IBA 12/2017
1	LipopolysaccharidesIBA 12/2017
1	PPAR gammaIBA 12/2017
1	Peptides (Polypeptides)IBA 08/2017
1	Galectin 3 (LGALS3)IBA 05/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2017
1	CollagenIBA 05/2017
1	CarbohydratesIBA 06/2016
1	Glucose (Dextrose)FDA LinkGeneric 06/2016
1	ElementsIBA 06/2016
1	Transcription Factors (Transcription Factor)IBA 06/2016
1	Carrier Proteins (Binding Protein)IBA 06/2016
1	ErbB Receptors (EGF Receptor)IBA 02/2015
1	PerhexilineIBA 02/2015
1	Bevacizumab (Avastin)FDA Link 01/2015
1	fotemustine (Muphoran)IBA 01/2015
1	AdipokinesIBA 03/2014
1	LipidsIBA 03/2014
1	VaccinesIBA 06/2012
1	Tyrosine (L-Tyrosine)FDA Link 06/2012
1	AntibodiesIBA 06/2012

Therapy/Procedure

2	Therapeutics 02/2015 - 06/2012
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2017
1	High-Frequency Ventilation 09/2016